Larvol Delta - Phase-I-Clinical-Study-of-AV1959R-Abetatargeting-AntiAlzheimer39s-Vaccine

AV-1959R - Nuravax

http://clinicaltrials.gov/ct2/show/NCT06831812

Feb 25, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next